[PDF] Top 20 Evaluation of Hologic Aptima HIV 1 Quant Dx Assay on the Panther System on HIV Subtypes
Has 10000 "Evaluation of Hologic Aptima HIV 1 Quant Dx Assay on the Panther System on HIV Subtypes" found on our website. Below are the top 20 most common "Evaluation of Hologic Aptima HIV 1 Quant Dx Assay on the Panther System on HIV Subtypes".
Evaluation of Hologic Aptima HIV 1 Quant Dx Assay on the Panther System on HIV Subtypes
... of HIV-1 subtype samples. A total of 277 well-characterized HIV-1 subtype samples were assembled from various sources to include 171 HIV-1 isolates cultured in peripheral blood ... See full document
7
Comparative performance of the new Aptima HIV-1 Quant Dx assay with three commercial PCR-based HIV-1 RNA quantitation assays
... from HIV-positive patients attending for care at the Royal Liverpool University Hos- pital, UK between January and December 2013 were used in this ...systems. HIV subtype was noted when available from ... See full document
7
Evaluation of the RealTime HIV 1, Xpert HIV 1, and Aptima HIV 1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV 1 v2 0 Assay for Quantification of HIV 1 Viral Load
... and Aptima assays correlated best with each other and with the RealTime ...major HIV-1 group M subtypes, although the RealTime assay tended to underestimate clade A1 and C ...v2.0 ... See full document
8
Multicenter Evaluation of Two Next Generation HIV 1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTime HIV 1 Reference Assay
... true HIV-1 virologic failure are critical for patient management, as patients typically visit physicians only twice per year in the United States or United Kingdom (4 times in ...current HIV-1 ... See full document
12
Evaluation of Performance Characteristics of the Aptima HIV 1 Quant Dx Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 in Plasma and Cervicovaginal Lavage Samples
... of HIV-1 RNA has been an established surrogate marker for monitoring viral suppression and drug efficacy during antiretroviral therapy (ART) in HIV-infected ...the HIV-1 concentration ... See full document
6
Evaluation of the Aptima HCV Quant Dx Assay Using Serum and Dried Blood Spots
... the evaluation of Aptima HCV performed on the Panther ...This assay demonstrated comparable performance to that of CAP/CTM on serum specimens collected from a ...Furthermore, Aptima HCV ... See full document
7
Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2 0
... the Aptima HCV Quant Dx (Aptima; Hologic, ...USA) assay. This is a quantitative HCV RNA assay for monitoring and diagnosing of HCV infection on the fully automated ... See full document
12
Performance of the New Aptima HCV Quant Dx Assay in Comparison to the Cobas TaqMan HCV2 Test for Use with the High Pure System in Detection and Quantification of Hepatitis C Virus RNA in Plasma or Serum
... the Hologic Aptima HCV Quant Dx assay (Aptima) to that of the Roche Cobas TaqMan HCV test, version ...Pure system (HPS/CTM), considered a reference assay since it ... See full document
7
Evaluation of the Aptima HIV 1 Quant Dx Assay Using Plasma and Dried Blood Spots
... TaqMan HIV-1 Test ...and assay setup, (ii) reverse transcription of the HIV-1 LTR and gag gene, and (iii) real-time PCR amplification and detection of target cDNA using fluorescently ... See full document
5
Evaluation of the Aptima HIV 1 Quant Dx Assay for HIV 1 RNA Quantitation in Different Biological Specimen Types
... 104 HIV-infected participants and prepared at the Center for AIDS Research (CFAR) at the University of ...posttreatment HIV loads, determined based on historical results from individual participants (dried ... See full document
10
Analytical characteristics and comparative evaluation of Aptima HIV 1 Quant Dx assay with Ampliprep/COBAS TaqMan HIV 1 test v2 0
... of Aptima and Roche CAP/CTM high correlation was seen between the re- sults in the two ...The Aptima assay gave slightly higher results compared to Roche CAP/CTM at the higher range of the ... See full document
9
An update on the use of Atripla<sup>®</sup> in the treatment of HIV in the United States
... York City, NY, USA) is a coformulated single pill composed of efavirenz, emtricitabine, and tenofovir disoproxil, intended as a once-daily potent combination antiretroviral therapeutic agent. Its efficacy is equivalent ... See full document
6
Click here to download PDF version of the article !
... of HIV-1 genomic ...of HIV-1 infections based on their origin of ...of HIV-1 strains carrying these common mutations is localized within ... See full document
5
Systematic Review of the Performance of HIV Viral Load Technologies on Plasma Samples
... There were no limitations on the method of nucleic acid extraction, amplification, or detection but the assays under investigation had to be commercially available at the time of the review. The study population was ... See full document
9
Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti human immunodeficiency virus 1 activity in vitro
... with HIV-1Ba-L is significantly suppressed in the presence of human ...only 1 h during monocyte viral exposure, inhibited HIV-1 infectivity for 3 wk after infection, whereas human plasma and ... See full document
10
Comparative evaluation of the performance of the Abbott RealTime HIV 1 assay for measurement of HIV 1 plasma viral load on genetically diverse samples from Greece
... of HIV-1 infection and constitutes an essential parameter of infection prog- nosis and optimal management of clinical patients ...plasma HIV-1 RNA levels in patients and therefore initiation ... See full document
11
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in North American Women by Testing SurePath Liquid Based Pap Specimens in APTIMA Assays
... and APTIMA GC, 92.5%) than the C. trachomatis tests (APTIMA COMBO 2, ...and APTIMA CT, ...for APTIMA COMBO 2, APTIMA CT, and APTIMA GC testing of ThinPrep samples transferred to ... See full document
5
An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
... treatment-naïve HIV patients, but its use in some settings is limited by adverse effects, particularly those affecting the central nervous system and lipid ... See full document
11
Effect of late HIV diagnosis on HIV-related mortality among adults in general hospitals of Central Zone Tigray, northern Ethiopia: a retrospective cohort study
... late HIV diagno- sis: implications for testing ...late HIV diagnosis among adult people living with HIV/AIDS who undertake an initial CD4 T cell evalua- tion, northern Ethiopia: a case-control ...of ... See full document
6
HIV 1 Gag C terminal amino acid substitutions emerging under selective pressure of protease inhibitors in patient populations infected with different HIV 1 subtypes
... the HIV Los Alamos database, this limits our analysis to address the clinical impact of the newly identified substitutions with large-scale ...different subtypes may develop different Gag substitutions ... See full document
8
Related subjects